Q3 2025 Management View CEO Marianne De Backer highlighted the completion of enrollment in ECLIPSE 1, Vir’s first ...

With his spectacular goal to make it 1-2, Jean-Luc Dompé provided one of the few positive HSV stories of the past weekend. In ...

India is witnessing a sharp rise in infectious diseases, with one in nine tests coming positive for dengue and influenza A, ...

1:2 in Leipzig, 0:1 against Wolfsburg, and now a 1:4 in Cologne: HSV has been unable to find their footing since the end of the October international break, at least in terms of sporting success in ...

A recent ICMR study has uncovered that 11.1% of patients tested in India are infected with significant pathogens, marking a ...

Following the recently announced positive Phase 3 topline results ... About Pritelivir Pritelivir, a novel helicase-primase inhibitor developed by Aicuris, targets both HSV-1 and HSV-2. These viruses ...

Pfizer's oncology portfolio has produced a second positive phase 3 trial in HER2-positive breast cancer in the span of about a year. This time, the drug that delivered the positive readout is Tukysa, ...

That the 49ers are 4–1 is remarkable enough—but to do so without a slew of their stars is another feat altogether. Now, San Francisco—once again looking like an NFC contender—may be eyeing the return ...

October has been designated as National Positive Attitude Month. While people around the country find themselves dealing with varying challenges, stresses and opportunities in their everyday lives, ...

Don’t sweat the fall stuff — including respiratory viruses. Cases of the common cold, flu, COVID-19 and respiratory syncytial virus (RSV) tend to increase in the autumn and winter as people spend more ...

They’ve lost three games already, two of which can be directly tied to his worrying habit for putting the football on the ground, but Derrick Henry still sees something positive in the Baltimore ...

2 Zhejiang Provincial Key Laboratory of Pancreatic Disease, Hangzhou, China Background Intrahepatic cholangiocarcinoma (ICC) is a highly aggressive malignancy with limited treatment options and poor ...